Rifamycin sodium salt

CAS No. 14897-39-3

Rifamycin sodium salt( —— )

Catalog No. M19784 CAS No. 14897-39-3

Rifamycin is an antibiotic that inhibits bacterial DNA-dependent RNA polymerase. It is effective against Gram-positive bacteria.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 41 In Stock
25MG 29 In Stock
50MG 36 In Stock
100MG 51 In Stock
200MG Get Quote In Stock
500MG 124 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rifamycin sodium salt
  • Note
    Research use only, not for human use.
  • Brief Description
    Rifamycin is an antibiotic that inhibits bacterial DNA-dependent RNA polymerase. It is effective against Gram-positive bacteria.
  • Description
    Rifamycin is an antibiotic that inhibits bacterial DNA-dependent RNA polymerase. It is effective against Gram-positive bacteria.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    Mycobacterium tuberculosis

Chemical Information

  • CAS Number
    14897-39-3
  • Formula Weight
    719.75
  • Molecular Formula
    C37H46NNaO12
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 90 mg/mL
  • SMILES
    [Na+].CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C2=O)c2c(O)cc(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c([O-])c2c(O)c3C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Riva S et al. Rifamycins: a general view. Annu Rev Microbiol. 1972;26:199-224.
molnova catalog
related products
  • LL-37, Human

    LL-37, Human is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity.

  • Sancycline

    A semi-synthetic tetracycline prepared by hydrogenolysis of the chloro and benzylic hydroxy moieties of Declomycin.

  • CB-618 sodium salt

    CB-618 (CB 238618) is a novel non-β-lactam β-lactamase inhibitor that potentiates meropenem MIC values against clinical Enterobacteriaceae isolates.